Cargando…
Change in Glycemic Control With Use of a Digital Therapeutic in Adults With Type 2 Diabetes: Cohort Study
BACKGROUND: Intensive lifestyle change can treat and even reverse type 2 diabetes. Digital therapeutics have the potential to deliver lifestyle as medicine for diabetes at scale. OBJECTIVE: This 12-week study investigates the effects of a novel digital therapeutic, FareWell, on hemoglobin A(1c) (HbA...
Autores principales: | Berman, Mark A, Guthrie, Nicole L, Edwards, Katherine L, Appelbaum, Kevin J, Njike, Valentine Y, Eisenberg, David M, Katz, David L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238888/ https://www.ncbi.nlm.nih.gov/pubmed/30291074 http://dx.doi.org/10.2196/diabetes.9591 |
Ejemplares similares
-
Achieving Rapid Blood Pressure Control With Digital Therapeutics: Retrospective Cohort and Machine Learning Study
por: Guthrie, Nicole L, et al.
Publicado: (2019) -
Emergence of digital biomarkers to predict and modify treatment efficacy: machine learning study
por: Guthrie, Nicole L, et al.
Publicado: (2019) -
SAT-LB120 A Software Application Delivering Behavioral Therapy Improved Glycemic Control in Adults With Type 2 Diabetes
por: Guthrie, Nicole L, et al.
Publicado: (2020) -
Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes
por: Hsia, Judith, et al.
Publicado: (2022) -
Egg ingestion in adults with type 2 diabetes: effects on glycemic control, anthropometry, and diet quality—a randomized, controlled, crossover trial
por: Njike, Valentine Y, et al.
Publicado: (2016)